Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

Hsin‐Kai Liao(Salk Institute for Biological Studies), Juan Carlos Izpisúa Belmonte(RAM Laboratories (United States))
Nature Communications
March 10, 2015
Cited by 335


Related Papers